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During 1993–2002, cats accounted for 2.7% of rabid 
terrestrial animals in New York but for one third of human 
exposure incidents and treatments. Nonbite exposures 
and animals of undetermined rabies status accounted for 
54% and 56%, respectively, of persons receiving rabies 
treatments.
R
abies has an almost 100% case-fatality rate and re-
quires considerable resources for control (1). In the 
United States, canine rabies is controlled with vaccination 
and control of dogs (2). Infection occurs primarily from 
bite wounds. In US cases diagnosed before death, patients 
died 6–43 days after clinical onset (3). Although <10 hu-
man cases have been diagnosed annually since 1990 (2) in 
the United States, potential exposure incidents and rabies 
postexposure prophylaxis (PEP) of humans are not rare. 
PEP is the treatment regimen for 1 person, with 2–5 vac-
cine injections and immune globulin, depending on prior 
vaccination history. PEP is unnecessary if an animal is not 
rabid at exposure.
A rabies outbreak in raccoons in the mid-Atlantic 
states in 1977 (4) reached New York state, which has many 
areas with land types favored by raccoons (5,6), in 1990. In 
this study, we identiﬁ  ed terrestrial rabies trends statewide 
in New York, with an aim toward prioritizing control. Pre-
vious analyses have focused on only part of the state (7) or 
on a shorter time period (8).
The Study
In New York, need for PEP is determined by outcome 
of 10-day conﬁ  nement (of all domestic animals) or labora-
tory testing (all species). Healthcare providers report sus-
pected rabies exposures to local health departments, which 
absorb authorized PEP costs beyond those borne by third-
party payers and partial reimbursement by the New York 
State Department of Health (9).
We analyzed exposure data collected electronically 
during 1993–2002. Exposures to bats and humans, animals 
submitted only for surveillance, and data from New York 
City (not part of the reporting system) were excluded. Ra-
bies was diagnosed by direct ﬂ  uorescent antibody staining. 
We analyzed data with SAS version 9.2 (SAS Institute, 
Cary, NC, USA) using US census data for rates (www.fact-
ﬁ  nder.census.gov). Because of skewed distributions, we 
used Spearman rank correlation coefﬁ  cients for measures 
of association.
The number of terrestrial animals submitted declined 
56% from 10,552 in 1993 to 4,631 in 2002. The number and 
proportion of rabid animals, which decreased from 2,637 
(25.0%) in 1993 to 608 (13.1%) in 2002, were strongly as-
sociated with the number of submitted animals (Spearman 
r = 0.99, p<0.0001).
For 70.4% of the 13,004 exposure incidents during 
1993–2002, an animal was not submitted for testing (Table 
1). These incidents accounted for 10,097 (55.6%) of the 
18,154 persons receiving PEP. Untestable and positive ani-
mals accounted for 2.6% and 23.4% of PEP, respectively. 
For 3.6% of exposure incidents, PEP began before rabies 
was ruled out.
Exposure incidents declined 45%, from 1,815 in 1993 
to 1,006 in 2001 (Figure 1). PEP decreased from 2,755 
(25.3 PEPs/100,000 persons) in 1993 to 1,327 in 2000 (12.1 
PEP/100,000 persons). Each year, the number of persons re-
ceiving PEP correlated with the number of submitted animals 
(Spearman r = 0.94, p<0.0001) and rabid animals (Spearman 
r = 0.95, p<0.0001). Although fewer cats (303) than raccoons 
(8,318) were rabid, cats accounted for the most exposure in-
cidents (4,266 [32.8%]) and PEP (5,777 [31.8%]) (Table 2). 
Dogs accounted for 3,052 (23.5%) exposure incidents and 
3,435 (18.9%) PEP. In New York, dogs and cats accounted 
for a high proportion of PEP from animals without rabies de-
termination (85.3% and 67.6%, respectively). Raccoons ac-
counted for 3,298 (25.4%) exposure incidents and for 5,210 
(28.7%) PEP. From 1993 to 2002, the proportion of PEP at-
tributed to raccoons changed from 48% to 22%; cats, from 
21% to 35%; and dogs, from 11% to 22%.
In 43 New York counties with populations <200,000, the 
PEP rate averaged 33.7/100,000 (range 8.4–81.3/100,000). 
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Table 1. Terrestrial rabies–associated exposure incidents and 
rabies PEP use, by animal test result, New York, USA, 1993–
2002*
Animal test result No. (%) incidents No. (%) PEP uses
Positive 3,047 (23.4) 7,032 (38.7)
Negative 469 (3.6) 551 (3.0)
Untestable 340 (2.6) 474 (2.6)
Not tested 9,148 (70.3) 10,097 (55.6)
Total 13,004 (100.0) 18,154 (100.0)
*Each rabies exposure situation in which >1 persons underwent PEP was 
defined as an incident. Excludes New York, NY. PEP, postexposure 
prophylaxis. The 14 larger counties (populations >200,000) had sig-
niﬁ  cantly lower PEP rates (9.8/100,000, range 0.5–21.8/
100,000; p<0.0001) and PEP per exposure incident 
(p<0.0001) but accounted for 42.6% of PEP.
During 1998–2002 when sex and age of exposed per-
sons were reported, data were missing for 211 of 7,221 
PEP reports. Persons who received PEP did not differ by 
sex (3,625 male, 3,569 female). PEP rates were highest for 
children 10–14 years of age (Figure 2). For male patients, 
PEP rates were lower in older age groups; for female pa-
tients, rates were highest in the 40–44-year group. Female 
patients received PEP signiﬁ   cantly more often because 
of cat exposures than did male patients (1,736 vs. 1,053; 
p<0.0001). Male patients received PEP signiﬁ  cantly more 
often from dog (984 vs. 583; p = 0.0005) and raccoon (767 
vs. 595; p = 0.05) exposures than did female patients. For 
each age group, except the >85-year age group, female 
patients received PEP more often from cat exposures and 
male patients more often from dog exposures.
The 8,405 bites accounted for 46.3% of PEP. A total 
of 1,114 (6.1%) of PEP occurrences were associated with 
scratch exposures and 3,707 (20.4%) with saliva/nervous 
tissue exposures. For indirect or unknown types of contact, 
4,298 (27.2%) PEP occurred. PEP for direct contact signiﬁ  -
cantly exceeded that for indirect or unknown contact for the 
study period (p<0.0001) and for each year except 1993. Bites 
accounted for signiﬁ  cantly more PEP because of dog and cat 
exposures (86.4% vs. 63.3%; p<0.0001) than did scratches 
or saliva/nervous tissue exposures. Raccoon exposures more 
frequently resulted from saliva/nervous tissue exposure than 
from bites (22.4% vs. 13.0%; p<0.0001). Most PEP resulting 
from indirect exposures (64.5%) was from raccoons.
Of 7,221 PEP occurrences during 1998–2002 when 
local health department authorization was reported, 6,846 
(94.8%) were reported as authorized. PEP start date was 
reported for 6,786 (94.0%). Of 6,264 persons not reported 
as previously vaccinated, 5,574 (89.0%) received 5 vac-
cine doses and 5,563 (88.8%) received human rabies im-
mune globulin. Of 522 persons previously vaccinated, 507 
(97.1%) received 2 vaccine doses.
PEP completion was not reported (no report received) 
for 716 (11%) persons; 701 had no prior treatment history. 
Most (79%) incomplete PEP in New York was associated 
with animals not captured for rabies determination. Of 119 
PEP associated with rabies-negative animals, 108 (91%) 
were not completed. PEP were not started for 17 (1%) and 
were not completed for 34 (2%) of the 2,217 PEP associated 
with rabid animals. Completion rates did not differ by pa-
tient sex. Most (697 [97%]) incomplete PEP was from direct 
contact exposures, primarily bites (87%). A total of 33 (9%) 
of 376 persons with adverse reactions did not complete treat-
ment. Incomplete PEP was associated more often with expo-
sures to dogs (42%) and cats (42%) than to other species.
The rate in New York was lower than that in Massachu-
setts when its epizootic was well established in 1995 (10), 
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Figure 1. Terrestrial rabies–associated exposure incidents and 
postexposure prophylaxis (PEP) use, by year, New York (excluding 
New York City), USA, 1993–2002.
Table 2. Terrestrial rabies–associated exposure incidents, number of rabid animals, and PEP use, by type of animal, New York, USA,
1993–2002*
PEP use
Animal
No. exposure 
incidents
Total no. rabid 
animals
Total no. 
uses
No. related to 
untested animals
No. related to 
nonbite incidents†
Wild
 Raccoon 3,298 8,318 5,210 1,488 4,534
 Fox 398 390 620 187 318
 Skunk 637 1,894 987 302 839
 Other 544 152 655 453 328
Domestic
 Dog 3,052 28 3,435 2,930 467
 Cat 4,266 303 5,777 3,907 2,119
 Other 187 143 668 63 625
Other/unknown 622 7 802 767 519
Total 13,004 11,235 18,154 10,097 9,749
*Each rabies exposure situation in which >1 persons underwent PEP was defined as an incident. Excludes New York, NY. PEP, postexposure 
prophylaxis. 
†Scratches, saliva/nervous system tissue exposure, mucous membrane exposure, indirect exposure, or unknown. Rabies and Postexposure Prophylaxis
perhaps because New York requires treating physicians to 
consult with local public health authorities. Similar to rates 
in New York, PEP rates in Ontario, Canada, decreased as fox 
rabies became enzootic and were weakly but signiﬁ  cantly 
associated with animal rabies (11). This association may be 
due to epizootic-related reductions in animal populations, 
resulting in fewer rabid animals and human contacts. Unlike 
New York, in Kentucky PEP occurred more frequently after 
exposures to dogs than cats (12). In Kentucky, the propor-
tion of incomplete PEP was the same as in New York (Mi-
chael Auslander, pers. comm., 2008). Treatment completion 
rates for New York and Kentucky were higher than those 
in a study of 11 US emergency departments (65%) (13). In 
Florida, 22% of PEP were inappropriate according to a state 
algorithm (14); in New York, local health departments report 
few unauthorized PEP administrations.
Conclusions
In New York, over time and with education, PEP as-
sociated with indirect exposures apparently can be reduced. 
Of most concern is the 55.6% of PEP associated with ani-
mals of undetermined rabies status. More efforts are need-
ed to capture exposing animals to rule out both rabies and 
the need for PEP. Capturing exposing animals should be a 
major component of animal control efforts that along with 
vaccination have been successful at reducing rabies risks.
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Figure 2. Rate of postexposure prophylaxis (PEP) use per 100,000 
persons per year, by sex and 5-year age groups, New York 
(excluding New York City), 1998–2002.